Year-end report 2012: Improved results in the business

  · Cost-cutting measures beginning to have an effect
  · Strong patient flow in all spine and orthopaedic clinics
  · Decreased vulnerability as a result of greater proportion of free-choice and
insurance company patients
  · Divestment of businesses has contributed to stronger balance sheet and an
improved financial position

FOURTH QUARTER 2012

  · Revenues increased by 10 percent to SEK 205.8m (186.8)
  · EBITDA amounted to SEK 17.3m (10.8)
  · The operating result before goodwill write-downs (EBITA) amounted to SEK
9.5m (3.5)
  · The operating result (EBIT) amounted to SEK 9.5m (-26.5)
  · The result before tax (EBT) amounted to SEK 6.8m (-27.7)
  · The result after tax (EAT) amounted to SEK 4.6m (-29.4)
  · The result per share amounted to SEK 0.04 (-0.46)

WHOLE YEAR 2012

  · Revenues increased by 7 percent to SEK 723.3m (675.2)
  · EBITDA amounted to SEK 29.6m (41.7)
  · The operating result before goodwill write-downs of SEK 36.8m (EBITA)
amounted to SEK -4.0m (15.2)
  · The operating result (EBIT) amounted to SEK -40.8m (-14.8)
  · The result before tax (EBIT) amounted to SEK -52.3m (-18.7)
  · The result after tax (EAT) amounted to SEK -59.1m (-28.6)
  · The result per share amounted to SEK -0.94 (-0.51)

THE CEO’S COMMENTS
We are very pleased with how we ended the year. Sales were the highest they have
ever been for a single quarter in Global Health Partner’s history. Results also
increased substantially, which is due, amongst other things, to lower costs,
both at the Group level and in the clinics. We took several important steps
during the year, even if sales and profits are still not at a satisfactory
level. The most important thing is our increasing focus, both geographically and
operationally.

Our main geographic focus is now to conduct specialist healthcare mainly in the
Nordic region. As a consequence of this focus we have now sold several clinics,
including the businesses in Prague and Cairo. At the same time we have acquired
new clinics during the year which complement our current business, for example a
gastro clinic at Odenplan in Stockholm and an orthopaedic clinic in Gildhøj in
Denmark. We also opened an orthopaedic clinic in Malmö that specialises in
sports injuries and hand surgery, Ortho Center Skåne, and during the spring a
new gastroenterology clinic was started, Gastro Center Göteborg.

These are businesses that are in line with our main focus since we have a high
level of expertise in these areas, and there are opportunities here to create
considerable synergies in terms of the revenue and cost side.

We see continuing price pressure in specialist healthcare across the board,
partly since a growing part of healthcare in the Nordic region is handled by
private clinics. At the same time Global Health Partner benefits from the fact
that the quality perspective is being given increasing prominence in the public
debate, which hopefully will result in a shift of focus from price to quality in
public procurement processes.

We are increasingly focusing on achieving synergies and reduced costs in our
business. We have accomplished a good deal here, but there is still a lot of
fine-tuning that remains to be done. It is a matter of all the time being more
and more efficient.

There is good underlying growth in our field, so it is also important to attract
patients to the clinics through the public system, via insurance companies and
not least where patients themselves are able to choose. The development of
increasing patient power will be to our advantage. The Patient Power Inquiry was
presented recently, and it proposes, amongst other things, a new patient law
that will clarify patients’ options and give patients more power and freedom to
choose their own healthcare. In addition it can be noted that the free choice of
hospital care (“vårdvalet”) is having an increasing impact, above all in
Stockholm where, for example, it is the turn of spine surgery and orthopaedics
this autumn, something that we assess is in our favour.

During 2013 we will continue to develop and expand the business in line with our
strategy at the same time as we will continue with our internal process of
becoming more efficient, so as to be able to achieve synergies as far as
possible, both on the cost side and the revenue side.

26 February 2013
Gothenburg
Global Health Partner AB (publ)

The Board
Queries should be addressed to:
Marianne Dicander Alexandersson, CEO, phone: +46-31 712 53 09
Tobias Linebäck, CFO and Head of Investor Relations, phone: +46-708 55 37 19
Global Health Partner is an internationally active healthcare provider that
operates specialist clinics in a select number of treatment areas through the
application of a business model that is unique in the healthcare industry, where
leading doctors become partners and shareholders. Multiple clinics with high
patient volumes within the same area of treatment produce increased efficiency
and higher quality, which is the cornerstone of Global Health Partner's business
philosophy – “Quality through Specialisation”. Global Health Partner’s shares
are traded on the Small Cap list at NASDAQ OMX Stockholm under the abbreviation
“GHP”.

Global Health Partner AB (publ) | www.globalhealthpartner.com
Corp. ID No. 556757-1103 | Östra Hamngatan 26-28 | SE-411 09 Gothenburg | Sweden
Tel +46-31 712 53 00 | Fax +46-31 313 13 21

Global Health Partner AB is required to publish the information herein according
to the Swedish Securities Market Act. This information was published on 26
February 2013 at 8.00 a.m. CET.

This report has not been the subject of review by the company’s auditor.

This is a translation of the Swedish version of the Year-end report. When in
doubt, the Swedish wording prevails.